SARS-CoV-2 variant detection and identification
Effective genomic surveillance of SARS-CoV-2 variants begins with the right tools
Used for qualitative detection of specific SARS-CoV-2 mutations
Easy to understand the instructions. SARS-CoV-2 Variant ValuPanel™ assays gives highly specific and quality results. Highly recommended
Review Date: 11 Sept 2021 | LGC Biosearch Technologies
Emerging SARS-CoV-2 variants will require global monitoring to ensure diagnostic tests, vaccines, and other antiviral therapies remain effective. As the virus’ mutations change its transmissibility and/or severity, public health control measures can stay ahead of the curve by analysing a subset of positive COVID-19 patient samples. These genomic surveillance programs include genotyping and sequencing the mutations, which can help characterise known variants and discover novel variants.
Product Overview
Links
Products Model Information
SARS-CoV-2 Variant ValuPanel™ assays
LGC Biosearch TechnologiesSARS-CoV-2 Variant ValuPanel™ assays consist of separately delivered probes and primers that are designed for qualitative detection of specific SARS-CoV-2 mutations by genotyping using reverse transcription-polymerase chain reaction (RT-PCR).